Alpha Paradigm Partners’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
FAM
ACH
BG
Alpha Paradigm Partners's CDNA Position: Q2 2022 in Review
Alpha Paradigm Partners sold out of CareDx (CDNA) in Q2 2022, closing a stake of 36,620 shares — an estimated $1.35M sold.
Alpha Paradigm Partners first reported a position in CDNA in Q4 2021 and held it in 2 quarters. The position peaked at $1.47M in Q4 2021. 184 funds tracked by Wall St. Rank hold CDNA as of Q2 2022.
- Alpha Paradigm Partners reported no remaining CareDx position as of Q2 2022 after selling out during the quarter.
- Alpha Paradigm Partners sold 36,620 CareDx shares in Q2 2022, an estimated $1.35M.
- Alpha Paradigm Partners first reported a position in CareDx in Q4 2021 and held it in 2 quarters.
- Alpha Paradigm Partners's CareDx position peaked at $1.47M in Q4 2021.
- 184 funds tracked by Wall St. Rank held CareDx as of Q2 2022.
Based on Alpha Paradigm Partners's 13F filing for Q2 2022, filed 15 Aug 2022.